ArticleJournal of immunotherapy and precision oncology2022

Treatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical Outcomes.

Leah Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.